Medical News

RSS

Cadence launches OFIRMEV pain medication in the U.S.

Cadence Pharmaceuticals, Inc. today announced the launch of OFIRMEV™ (acetaminophen) injection, the first and only intravenous (IV) formulation of acetaminophen to be approved in the United States. The U.S. Food and Drug Administration (FDA) approved OFIRMEV in November 2010 for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever.

18 Jan 2011

PROLOR and Yeda enter definitive license agreement for Reversible PEGylation technology

PROLOR Biotech, Inc., today announced that it has entered into a definitive license agreement with Yeda Research and Development Company Ltd. for novel technology utilized in the development of long-acting therapeutic peptides and small molecules, termed Reversible PEGylation.

18 Jan 2011

Positive results from Cook Medical's REFORM stent clinical trial for treatment of renal artery stenosis

Study investigators today reported initial data from Cook Medical's REFORM clinical trial that is aimed at assessing the safety and effectiveness of the company's balloon-expandable renal stent for the treatment of renal artery stenosis. The data, presented by Robert Bersin, M.D., at ISET 2011, reveal a nine-month primary patency rate of 89.5 percent and a 97 percent rate of successful delivery and deployment of the stent.

18 Jan 2011

Alexza completes FDA review for AZ-004 NDA

Alexza Pharmaceuticals, Inc. announced today that it completed an End-of-Review meeting with the U.S. Food and Drug Administration (FDA or Agency) for the AZ-004 New Drug Application (NDA), and has received the official FDA minutes from the meeting. In December 2010, Alexza held the End-of-Review meeting in response to a Complete Response Letter (CRL) received in October 2010.

18 Jan 2011

Mylan receives FDA approval for generic Precose Tablets ANDA

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Acarbose Tablets, 25 mg, 50 mg and 100 mg, the generic version of Bayer's Precose® Tablets, a treatment to be used with diet and exercise to improve glycemic control in adults with type 2 diabetes.

18 Jan 2011

First Edition: January 18, 2011

Today's headlines feature reports about the upcoming repeal vote in the House as well as news about a government report that attempts to quantify the number of Americans who have preexisting conditions.

18 Jan 2011

Ingenuity and Erasmus enter next-generation sequencing disease research collaboration

Ingenuity® Systems, a leading provider of information solutions for life science researchers, and Erasmus Medical Center, jointly announced a scientific collaboration using next-generation sequencing (NGS) for disease research.

18 Jan 2011

New study unravels neural mechanisms underlying inability to express emotions

This German study demonstrates that the supragenual anterior cingulate cortex (ACC) is constantly activated more strongly in alexithymic subjects and that this activation is related to the symptoms of alexithymia and not to associated symptoms such as depression. These findings also support the hypothesis of an altered function of the ACC in alexithymia.

18 Jan 2011

Orchid Cellmark executes multi-year contract with U.K. Child Maintenance and Enforcement Commission

Orchid Cellmark, a leading worldwide provider of identity DNA testing services, today announced it has executed a multi-year contract with the U.K. Child Maintenance and Enforcement Commission (CMEC), formerly the Child Support Agency (CSA), for the exclusive provision of DNA paternity testing services. Orchid Cellmark delivers its paternity testing services in the U.K. under the Cellmark brand.

18 Jan 2011

Potential device to treat post-operative cognitive decline

It's called post-operative cognitive decline, a syndrome in which patients experience memory loss or other forms of cognitive dysfunction after surgery or critical illness.

18 Jan 2011

Annual Society for Endocrinology BES conference to take place in UK from 11-14 April 2011

The annual Society for Endocrinology BES conference is taking place in Birmingham, UK from 11-14 April 2011.

18 Jan 2011

Heart failure patients admitted to general wards twice as likely to die

Heart failure patients admitted to general wards are twice as likely to die as those admitted to cardiology wards, shows a national audit of the treatment of the condition, published online in the journal Heart.

18 Jan 2011

Biological Psychiatry publishes special issue focusing on postmortem studies of psychosis

Biological Psychiatry is proud to announce this week's publication of a special issue focusing on postmortem studies of psychosis. This special issue showcases the use of human brains postmortem to study psychiatric disorders, focusing on schizophrenia. The review articles highlight the benefits, achievements, problems, and perhaps most importantly, the future of postmortem research.

18 Jan 2011

CHF: Over 5 million children will lose insurance coverage under new health care policy

Children's Health Fund (CHF) today urged lawmakers to vote against the repeal of health care reform legislation, which would jeopardize the long-term health of millions of children across the nation. CHF estimates that more than 5 million children would lose the promise of insurance coverage under the new health care policy, if a full repeal is successful.

18 Jan 2011

Individuals with intensive educational intervention have better health behaviors: Study

A new study conducted by researchers at Columbia University's Mailman School of Public Health examines this issue, using data from a the well-known Carolina Abecedarian Project, a randomized control study that enrolled 111 infants in the 1970s and continued to follow them through age 21. Researchers found that individuals who had received the intensive education intervention starting in infancy had significantly better health and better health behaviors as young adults.

18 Jan 2011

Critical Diagnostics' Presage ST2 Assay effectively risk-stratifies chronic heart failure patients

Critical Diagnostics, the exclusive developer of the Presage® ST2 Assay, announces the publication of the Penn Heart Failure Study (PHFS) in an advance e-publication of the January 19, 2010 edition of Circulation: Heart Failure. The results of this study demonstrated that ST2 levels not only predict outcomes for ambulatory outpatients with chronic heart failure, they more effectively risk-stratify such patients.

18 Jan 2011

Quebec reimburses VIDAZA for treatment of blood cancer

Quebec patients with serious blood cancers (intermediate-2 and high-risk myelodysplastic syndrome and acute myeloid leukemia) now have publicly funded access to a new innovative therapy, VIDAZA® (azacitidine). Following a priority review and subsequent positive recommendation from the Conseil du medicament, patients now have the potential to significantly extend survival.

18 Jan 2011

Hamilton Academy of Medicine launches campaign to increase awareness about smoking cessation

In honour of National Non-Smoking Week, The Hamilton Academy of Medicine is proud to introduce, It's Hamilton's Time to Quit, a campaign designed to increase awareness about local quitting resources and tools to help the community understand the support that is available, and encourage people to seek the assistance they need to stop smoking.

18 Jan 2011

eCareSoft's eCS receives Complete Inpatient EHR Certification

eCareSoft's eCS has received Complete Inpatient EHR Certification deeming the electronic health record (EHR) software capable of enabling hospitals and their affiliates to meet the Stage 1 meaningful use measures required to qualify for funding under the American Recovery and Reinvestment Act (ARRA).

18 Jan 2011

Hotspur announces successful completion of GPSCath Catheter in peripheral angioplasty surgery

Hotspur Technologies, announced today that Dr. Greg Sampognaro, Interventional Cardiologist at P & S Surgical Hospital in Monroe, Louisiana, successfully completed the first use of the GPSCath Balloon Dilatation Catheter in an intervention to treat a blocked peripheral artery.

18 Jan 2011

Medical News

Cadence launches OFIRMEV pain medication in the U.S.

PROLOR and Yeda enter definitive license agreement for Reversible PEGylation technology

Positive results from Cook Medical's REFORM stent clinical trial for treatment of renal artery stenosis

Alexza completes FDA review for AZ-004 NDA

Mylan receives FDA approval for generic Precose Tablets ANDA

First Edition: January 18, 2011

Ingenuity and Erasmus enter next-generation sequencing disease research collaboration

New study unravels neural mechanisms underlying inability to express emotions

Orchid Cellmark executes multi-year contract with U.K. Child Maintenance and Enforcement Commission

Potential device to treat post-operative cognitive decline

Annual Society for Endocrinology BES conference to take place in UK from 11-14 April 2011

Heart failure patients admitted to general wards twice as likely to die

Biological Psychiatry publishes special issue focusing on postmortem studies of psychosis

CHF: Over 5 million children will lose insurance coverage under new health care policy

Individuals with intensive educational intervention have better health behaviors: Study

Critical Diagnostics' Presage ST2 Assay effectively risk-stratifies chronic heart failure patients

Quebec reimburses VIDAZA for treatment of blood cancer

Hamilton Academy of Medicine launches campaign to increase awareness about smoking cessation

eCareSoft's eCS receives Complete Inpatient EHR Certification

Hotspur announces successful completion of GPSCath Catheter in peripheral angioplasty surgery

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News